Edwards Lifesciences Issuance Purchase of Equity Shares Trend

EW -- USA Stock  

USD 152.87  0.69  0.45%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Issuance Purchase of Equity Shares of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from common equity changes. Includes additional capital contributions from share issuances and exercise of stock options, and outflow from share repurchases.
Issuance Purchase of Equity Shares10 Years Trend
Slightly volatile
 Issuance Purchase of Equity Shares 

Regression Statistics

Arithmetic Mean (255,556,680)
Coefficient Of Variation (72.14)
Mean Deviation  145,063,096
Median (242,700,000)
Standard Deviation  184,369,999
Range  541,900,000
R Value (0.78)
R Squared  0.61
Significance  0.001619
Slope (36,979,237)

Edwards Lifesciences Issuance Purchase of Equity Shares Over Time

2016-12-31 (559,000,000) 
2017-12-31 (559,000,000) 
2018-12-31 (395,736,842) 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.